624 related articles for article (PubMed ID: 18360280)
21. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
22. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
23. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.
Di Sabatino A; Ciccocioppo R; Cupelli F; Cinque B; Millimaggi D; Clarkson MM; Paulli M; Cifone MG; Corazza GR
Gut; 2006 Apr; 55(4):469-77. PubMed ID: 16105889
[TBL] [Abstract][Full Text] [Related]
24. Refractory coeliac disease.
Daum S; Cellier C; Mulder CJ
Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
[TBL] [Abstract][Full Text] [Related]
25. Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease.
Trejdosiewicz LK; Calabrese A; Smart CJ; Oakes DJ; Howdle PD; Crabtree JE; Losowsky MS; Lancaster F; Boylston AW
Clin Exp Immunol; 1991 Jun; 84(3):440-4. PubMed ID: 1828397
[TBL] [Abstract][Full Text] [Related]
26. Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort.
O'Shea U; Abuzakouk M; O'Morain C; O'Donoghue D; Sheahan K; Watson P; O'Briain S; Alexander D; Catherwood M; Jackson J; Kelly J; Feighery C
J Clin Pathol; 2008 Nov; 61(11):1200-2. PubMed ID: 18955575
[TBL] [Abstract][Full Text] [Related]
27. Cladribine therapy in refractory celiac disease with aberrant T cells.
Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
[TBL] [Abstract][Full Text] [Related]
28. Age-associated increase in number of CD4+CD8+ intestinal intraepithelial lymphocytes in rats.
Takimoto H; Nakamura T; Takeuchi M; Sumi Y; Tanaka T; Nomoto K; Yoshikai Y
Eur J Immunol; 1992 Jan; 22(1):159-64. PubMed ID: 1370412
[TBL] [Abstract][Full Text] [Related]
29. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.
Daum S; Weiss D; Hummel M; Ullrich R; Heise W; Stein H; Riecken EO; Foss HD;
Gut; 2001 Dec; 49(6):804-12. PubMed ID: 11709515
[TBL] [Abstract][Full Text] [Related]
30. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis.
Oberhuber G; Vogelsang H; Stolte M; Muthenthaler S; Kummer JA; Radaszkiewicz T
Am J Pathol; 1996 May; 148(5):1351-7. PubMed ID: 8623906
[TBL] [Abstract][Full Text] [Related]
31. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
32. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
33. Enteropathy associated T cell lymphoma.
Wright DH
Cancer Surv; 1997; 30():249-61. PubMed ID: 9547996
[TBL] [Abstract][Full Text] [Related]
34. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.
Schmitz F; Tjon JM; Lai Y; Thompson A; Kooy-Winkelaar Y; Lemmers RJ; Verspaget HW; Mearin ML; Staal FJ; Schreurs MW; Cupedo T; Langerak AW; Mulder CJ; van Bergen J; Koning F
Gut; 2013 Apr; 62(4):509-19. PubMed ID: 22760007
[TBL] [Abstract][Full Text] [Related]
35. Peripheral T-cell lymphomas of the intestine.
Chott A; Dragosics B; Radaszkiewicz T
Am J Pathol; 1992 Dec; 141(6):1361-71. PubMed ID: 1466400
[TBL] [Abstract][Full Text] [Related]
36. Lymphokine-activated killing by human intestinal lymphocytes.
Ebert EC; Roberts AI
Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
[TBL] [Abstract][Full Text] [Related]
37. Immune modulation by non-hodgkin lymphoma in a patient with two primary intestinal T-cell lymphomas and long-standing celiac disease.
Mühr-Wilkenshoff F; Friedrich M; Foss HD; Hummel M; Zeitz M; Daum S
Digestion; 2010; 81(4):231-4. PubMed ID: 20110707
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
[TBL] [Abstract][Full Text] [Related]
39. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma.
Ashton-Key M; Diss TC; Pan L; Du MQ; Isaacson PG
Am J Pathol; 1997 Aug; 151(2):493-8. PubMed ID: 9250161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
